0001127602-19-003737.txt : 20190204
0001127602-19-003737.hdr.sgml : 20190204
20190204161308
ACCESSION NUMBER: 0001127602-19-003737
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190131
FILED AS OF DATE: 20190204
DATE AS OF CHANGE: 20190204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Babu Yarlagadda S
CENTRAL INDEX KEY: 0001452635
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 19563814
MAIL ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-01-31
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001452635
Babu Yarlagadda S
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Senior VP - Drug Discovery
Common Stock
2019-01-31
4
M
0
19686
1.20
A
127786
D
Common Stock
2019-01-31
4
F
0
7702
8.68
D
120084
D
Common Stock
2019-01-31
4
M
0
12188
1.20
A
132272
D
Common Stock
2019-01-31
4
F
0
1685
8.68
D
130587
D
Non-Qualified Stock Option
1.20
2019-01-31
4
M
0
19686
0
D
2010-03-02
2019-03-02
Common Stock
19686
0
D
Emp. Stock Option (Right to Buy)
1.20
2019-01-31
4
M
0
12188
0
D
2010-03-02
2019-03-02
Common Stock
12188
0
D
Shares of Common Stock delivered to the Company to satisfy payment of exercise price and tax withholding in connection with stock option exercise.
Shares of Common Stock delivered to the Company to satisfy payment of exercise price in connection with stock option exercise.
/s/ Alane P. Barnes, by power of attorney
2019-02-04